Last reviewed · How we verify
NCT06961604
A Novel Method for Determination of Thromboembolic Stroke Origin
EARLY_PHASE1 trial testing NaF PET-CT in Thromboembolic Stroke in 20 participants. Not yet recruiting.
1 June 2025
Quick facts
| Lead sponsor | Atlantic Health System |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 20 |
| Start date | 1 June 2025 |
| Primary completion | 1 June 2025 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- NaF PET-CT — full drug profile →
Conditions studied
- Thromboembolic Stroke — all drugs for Thromboembolic Stroke →
Sponsor
Atlantic Health System — full company profile →
Who can join
18 and older, any sex, with Thromboembolic Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rupture of vulnerable carotid, vertebral, and intracranial arterial plaques results in thromboembolic stroke. Identification of these culprit lesions is an important component of post-stroke care. This study seeks to test the feasibility of NaF PET-CT to detect these plaques and alter patient care. Prior studies have shown a high degree of correlation between NaF PET+ lesions and high-risk plaque features on high resolution MRI, including mirocalcification, necrosis, and ulceration.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06961604
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Atlantic Health System trials
Trials by the same sponsor.
- NCT07445958 — In-Clinic Assessment of Vaginal Mucosal Safety Following Repetitive Use of the Livi Device · NA · completed
- NCT07309029 — Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR · recruiting
- NCT06810687 — Is Methenamine Prophylaxis for Urinary Tract Infection After Midurethral Sling as Effective as Antibiotic Prophylaxis? · NA · recruiting
- NCT06738615 — Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity · recruiting
- NCT06530186 — Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06961604 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Atlantic Health System
- Last refreshed: 8 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06961604.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing